[ad_1] Shots: Madrigal has entered into an exclusive global license agreement with Pfizer for ervogastat (PF-06865571; PO) to treat metabolic dysfunction-associated steatohepatitis (MASH) As per the deal, Madrigal will receive an exclusive global license to develop, manufacture & commercialize ervogastat & 2 additional early-stage MASH assets, paying Pfizer $50M upfront with further milestone payments &…
[ad_1] Life Extension is kicking off its Super Sale with a rare sitewide offer that applies to every supplement in its catalogue, including best sellers and newly released formulas, just in time for the holiday season. For a limited time, Life Extension is offering 10% off all supplements as part of its Super Sale campaign,…
[ad_1] Olive Oil Orange Yogurt Coffee Cake Beautiful orange coffee cake baked with fresh orange juice and zest, olive oil and Greek yogurt for moisture, and a perfectly sweet, crunchy streusel topping. Add chocolate chips for a delicious chocolate orange flavor boost, and make it extra special with a simple orange glaze. This orange coffee…
[ad_1] Sweet Potato Hash Baked Egg Cups are a delicious make-ahead recipe that’s light and easy to make. These Egg Cups are perfect for brunch, breakfast or lunch. Easy Breakfast Egg Cups When Maddie was first born, a friend of mine brought some Prosciutto Egg Cups over. They were absolutely delicious and super filling. I knew…
[ad_1] Even in the darkest of times, biopharmaceutical investors and executives usually express optimism in January, when thousands gather in San Francisco for the annual J.P. Morgan Healthcare Conference to discuss where the industry is headed. As the 2026 meeting begins, though, they have reason to feel hopeful. Several indicators of sector health, from stock…
[ad_1] Navigating cold chain supply within the market scope of the life sciences industry demands uncompromising performance. Temperature excursions, packaging failures and inconsistent thermal protection can jeopardize product integrity, create compliance issues and risk patient safety. There is a large carbon footprint associated with shipping critical products across the world and companies face growing pressure…
[ad_1] Selecting the proper clinical outcome assessment (COA) can set the tone for an entire trial’s success. Yet for many clinical researchers, COA selection remains one of the most misunderstood and delayed aspects of study design. The result? Missed alignment, slower timelines, and data that may not fully capture what truly matters. In a time…
[ad_1] Experts from Quotient Sciences present a roadmap for moving novel drugs to market more quickly. Novel therapies, such as those for rare diseases, meet vital patient needs but it can be hard to formulate the optimum regulatory approach to ensure they reach the market as quickly as possible. Several pathways are in place to…
[ad_1] Five maternal deaths since 2021: Trichy hospital faces one-month suspension We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] YL201 is an ADC that targets B7H3 and has been developed with MediLink’s proprietary TMALIN platform. Credit: Alpha Tauri 3D Graphics / Shutterstock.com. MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of YL201, an investigational antibody-drug conjugate (ADC) targeting B7H3 in various solid tumour types. Under the…